Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study by Mayer, Erica L, MD, Dueck, Amylou C, PhD, Martin, Miguel, Prof, Rubovszky, Gabor, PhD, Burstein, Harold J, Prof, Bellet-Ezquerra, Meritxell, MD, Miller, Kathy D, MD, Zdenkowski, Nicholas, PhD, Winer, Eric P, Prof, Pfeiler, Georg, MD, Goetz, Matthew, Prof, Ruiz-Borrego, Manuel, MD, Anderson, Daniel, MD, Nowecki, Zbigniew, MD, Loibl, Sibylle, Prof, Moulder, Stacy, Prof, Ring, Alistair, FRCP, Fitzal, Florian, MD, Traina, Tiffany, MD, Chan, Arlene, Prof, Rugo, Hope S, Prof, Lemieux, Julie, MD, Henao, Fernando, MD, Lyss, Alan, MD, Antolin Novoa, Silvia, MD, Wolff, Antonio C, Prof, Vetter, Marcus, MD, Egle, Daniel, MD, Morris, Patrick G, Prof, Mamounas, Eleftherios P, Prof, Gil-Gil, Miguel J, MD, Prat, Aleix, Prof, Fohler, Hannes, MVM, Metzger Filho, Otto, MD, Schwarz, Magdalena, MSc, DuFrane, Carter, BA, Fumagalli, Debora, MD, Theall, Kathy Puyana, MD, Lu, Dongrui Ray, MS, Bartlett, Cynthia Huang, MD, Koehler, Maria, MD, Fesl, Christian, PhD, DeMichele, Angela, Prof, Gnant, Michael, Prof

Get full text